Brigatinib API Market to Reach 89.7 Million by 2034 Driven by Rising Lung Cancer Cases
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...
0 التعليقات 0 المشاركات 23 مشاهدة 0 معاينة
Zepky https://zepky.com